What is peptide laboratory record traceability in an analytical laboratory?
Peptide laboratory record traceability is a property of the record set, not a slogan on a certificate. A result is traceable when it can be related to a stated reference through a documented, unbroken chain of comparisons, each contributing a recorded uncertainty. In a peptide laboratory the result may be an intact mass, a chromatographic area-percent, a related-substance relative retention time, a water value or a counter-ion figure. The reference may be an in-house qualified standard or a higher-order preparation. Zhang and colleagues reported that the commutability of thyroid-stimulating hormone international reference preparations plays an important role in metrological traceability (PMID:41539641). Naming a peptide standard without its lot, matrix, assigned value and fitness-for-purpose evidence does not create that chain.
A batch number on a vial is necessary and not sufficient. Traceability fails when the vial label, the chromatography data-system sample name, the sequence table and the certificate header cannot be shown to denote the same physical portion. It also fails when the processing method that produced the reported purity is not the version stored with the raw file, or when a sign-off exists without an audit-trail entry showing who integrated which peaks and when. Attributable, legible, contemporaneous, original and accurate records — the ALCOA set, often extended by completeness, consistency, endurance and availability — are the practical test. A scanned chromatogram that cannot be opened in the native format, or a spreadsheet with formulae pasted as values, is a copy, not the original.
For Australian research procurement the chain crosses an organisational boundary. The supplier batch pack and the receiving notebook are separate systems. Peptide laboratory record traceability across that boundary needs a shared identifier set and a written rule for which system owns each fact. Local stock status and a tracked dispatch reference are custody facts; they do not replace analytical identifiers. The completed chain shows which container, which procedure version and which raw file support a reported figure. Reconstruction should be possible from the written record alone: a second analyst, without speaking to the first, should be able to name the balance, the diluent lots, the sequence position and the processing method that yielded the figure. That standard is analytical and documentary.
Which identifiers should be fixed before a peptide sample is prepared for analysis?
A traceable peptide record starts at receipt, not at the first chromatogram. Assign a laboratory sample identifier and, in the same controlled row, record the supplier lot, catalogue or material code, vial identifier, product name, counter-ion form if stated, labelled net-content unit, and the date the container was opened for analytical work. Those fields join a weighing to a sequence and a certificate. If two vials share a supplier lot, each still needs a unique container identifier. A documentation pack describes the lot, not every handling event after opening.
The preparation record should capture the balance identifier and calibration-status date, the mass taken, the identity and lot of each diluent or mobile-phase component, the volumetric apparatus identifier, the final volume and the calculated analytical concentration. Units must be explicit; a bare number is not reconstructable. Preparation time, analyst and hold time before the solution meets the instrument belong on the same form. An out-of-trend peak area cannot be investigated if solution age is unknown. This is a measurement-control record for the analytical procedure. Solution concentration here is a calculated analytical value used to interpret the chromatogram, and it is stored with the balance, volumetric and diluent identifiers that produced it.
Fix naming rules before the campaign. Concatenate laboratory sample ID, supplier lot and a preparation suffix, and forbid free-text edits once the sequence is locked. Blank, system-suitability and bracketing-standard positions need identifiers, including the reference-material lot. Jan and colleagues reported an LC-MS/MS label-free quantification study that characterised proteins in Schizothorax labiatus (PMID:37349327). Such a dataset remains interpretable only when the sample list stays attached to the raw files. A single-peptide purity run is smaller, but if the data-file name does not match the notebook, the peak table cannot be attributed.
A label lot that does not match the certificate header, a missing vial identifier or an unlabelled diluent should stop the sequence. Altering paperwork after acquisition breaks contemporaneous recording. If work continues under a planned investigation, the deviation record must cite the original identifiers rather than replace them.
How should HPLC and LC-MS raw files be bound to the peptide batch record?
Binding a chromatogram to a batch is a data-integrity task. The data system should store a result set whose sample identifiers were taken from a locked sequence, not retyped into a report template. For each run retain the instrument identifier, column or cartridge serial, detector or mass-analyser settings actually used, method-file name and version, processing-method name and version, the sequence table, and system-generated date-time stamps. If purity is reported from an ultraviolet channel and identity from an orthogonal mass spectrum, both files must carry the same sample identifier and a cross-reference.
System suitability belongs in the procedure control strategy. ICH Q2(R2) treats validation — the documented evidence that selected characteristics show the procedure is fit for the intended measurement — as a record, not as an assumption carried forward from development. In routine files that principle appears as a suitability block: responses, retention windows, resolution or peak-shape metrics the procedure requires, the reference-material lot, and a pass or fail decision recorded before sample results are reported. Overwriting a suitability failure by reprocessing, without an audit-trail reason, destroys the original even if the certificate looks clean.
The reported figure and the peak table must reconcile. For area-normalised purity, show which peaks were included, which blank or solvent peaks were excluded, the reporting threshold and the calculation. Manual integration, where the procedure allows it, needs a reason code, the original automatic baseline, and second-person review. ICH Q14 expects a defined control strategy and a clear description of the reportable result, so later changes can be judged against what the procedure was designed to deliver. Changing integration rules outside that description is a procedure change, and the batch record should say so.
Keep the native file, not only a flattened export. The original is the vendor file plus the audit trail, readable for the laboratory's defined retention period. File names should embed the laboratory sample ID and the result ID, mapped by a controlled index to the certificate revision. If a supplier provides only a PDF, record that limitation.
How do ICH Q14 and ICH Q2(R2) structure traceable analytical procedure records?
A batch file is traceable to a procedure only if the procedure has a controlled history. ICH Q14 describes a science- and risk-based lifecycle: define what the measurement must achieve, develop the procedure against that definition, and maintain it as knowledge accumulates. The analytical target profile is the prospective statement of required characteristics. For a research peptide it may require identity within a stated mass window, related substances reported above a stated threshold, and a purity or content result whose accuracy and precision have been shown over a stated range.
Q14 distinguishes a minimal approach from an enhanced approach. The enhanced approach adds structured risk assessment, prior-knowledge capture and, where justified, established conditions — parameters that must stay controlled because they influence the reportable result — plus a wider region supported by development data. Either approach fails if development experiments are not attributable to method versions. A gradient copied onto a certificate without a method identifier does not show whether it is the validated procedure or an abandoned scout run.
ICH Q2(R2) is the companion evidence that the procedure meets its intended measurement purpose. An identification test centres on specificity. A related-substance procedure centres on specificity, accuracy, precision and a justified reporting threshold, with quantitation limits where the measurement purpose requires them. An assay centres on accuracy, precision, range and specificity against likely interferences, including diluent peaks. Q2(R2) does not set a universal peptide purity percentage. The laboratory specification sets numerical acceptance criteria, and the validation report must show the data used to justify them. Intermediate precision, as designed in the protocol, belongs in that report. One suitability run on a release day does not establish it.
Link these documents to the batch file by identifiers, not by a vague compliance sentence. Cite procedure identifier, version and validation-report identifier. A change to column chemistry, ion-pair reagent, detection wavelength, integration rules or preparation solvent is assessed under the change approach Q14 describes. The decision — no impact, partial revalidation or full revalidation — is its own record.
How does reconciliation complete peptide laboratory record traceability for an Australian laboratory?
Reconciliation is where peptide laboratory record traceability closes or fails. Before any supplier figure is transcribed, compare four surfaces: container label, certificate header, chromatogram or spectrum sample name, and the laboratory receipt record. Require agreement on material name, supplier lot and, where the pack is vial-specific, container identifier. The receipt record should hold the date of receipt, the tracked dispatch reference, and whether the goods were drawn from Australian stock or another stated location. They do not authenticate identity or purity.
Check numerical concordance separately. Purity, related-substance and identity figures in the certificate summary should match the peak table and mass report in the same pack, within the supplier's stated rounding rule. If the summary states one area-percent and the peak table sums to another, the pack is not internally traceable, however close either figure sits to a specification. When the laboratory repeats testing, its sample identifier must point back to the supplier lot, and the repeat result is a new record, not an overwrite.
Categorise mismatches in a written procedure. A header-to-label lot mismatch is an identity-of-record failure: quarantine the material from further analytical work until a corrected, version-controlled pack arrives. A missing processing method, or a PDF with no result ID, is a completeness failure. A net-content figure that omits counter-ion or water correction is a definition mismatch. Do not correct it silently in a spreadsheet. Each category yields a record: who found it, which identifiers were involved, the decision, and any revised document version.
Retention and review finish the chain. Set a retention period that covers the project and any re-test. Keep a review signature attributable to a person and a date-time. Second-person review should confirm identifier concordance and arithmetic, not merely that a file opens. A record that only one analyst can open, on one workstation without backup, is not available. It establishes only what was tested, by which procedure, against which reference, and with which result. The reviewer's conclusion is limited to concordance of identifiers, completeness of the file set and agreement of the arithmetic with the stated calculation. A useful review note cites the result identifier, the procedure version and the reference lot, and it records whether native files or only a flattened export were available for inspection.
Frequently asked questions
What is peptide laboratory record traceability?
It is the ability to reconstruct how a reported peptide result was produced, from the labelled container through preparation, acquisition, processing and review, back to a stated reference. A lot number is one identifier in that chain. Traceability also requires method version, raw-data identity, calibration records and an attributable review. It is a documentation property of the analytical record. Associated research materials are not for human use.
Does a PDF certificate satisfy traceability on its own?
A PDF can present results, but it is not automatically the original record. Traceability needs concordance between the label, the certificate header and the sample name on the chromatogram or spectrum, plus a pointer to the method version and, where available, the native data file and audit trail. If only a PDF is supplied, the laboratory should record that limitation rather than assume the underlying files exist.
Which ICH guidelines apply to these analytical records?
ICH Q14 covers analytical procedure development, including the analytical target profile, knowledge capture and change management across the procedure lifecycle. ICH Q2(R2) covers validation evidence that the procedure is fit for its intended measurement, including the characteristics and the report that holds the data. Neither guideline sets a universal peptide purity percentage. The laboratory specification and the cited report identifiers do that work.
Why does reference-preparation commutability belong in a peptide record?
Zhang and colleagues reported that commutability of thyroid-stimulating hormone international reference preparations plays an important role in metrological traceability. The peptide lesson is methodological and remains inside the analytical record. A calibration hierarchy is only as sound as the recorded identity, matrix and assigned value of the reference, and any evidence that the reference behaves like the samples measured. Printing a reference name without those fields does not make a purity or content result traceable.
What should the laboratory do if the label lot and the certificate lot disagree?
Treat the disagreement as an identity-of-record failure. Do not start, or do not continue, analytical work that would mix the two identifiers. Quarantine the container from further measurement use until a version-controlled correction arrives, and keep the original labels in the deviation record rather than overwriting them. Logistics details such as tracked dispatch or Australian stock status cannot resolve an identifier mismatch.
References
- PMID:37349327 — LC-MS/MS based characterisation and differential expression of proteins in Himalayan snow trout, Schizothorax labiatus using LFQ technique — Sci Rep — 2023
- PMID:41539641 — The commutability of thyroid-stimulating hormone international reference preparations plays an important role in metrological traceability — Clin Chim Acta — 2026
- URL:https://database.ich.org/sites/default/files/ich_q2-r2_guideline_2023_1130.pdf — ICH Q2(R2) Validation of Analytical Procedures — International Council for Harmonisation — 2023
- URL:https://database.ich.org/sites/default/files/ich_q14_guideline_2023_1116.pdf — ICH Q14 Analytical Procedure Development — International Council for Harmonisation — 2023
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
